Posted by Michael Wonder on 09 Feb 2016
Promius Pharma receives FDA approval for Sernivo (betamethasone dipropionate) 0.05% topical spray
8 February 2016 - Sernivo topical spray, a prescription steroid, is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older.
For more details, go to: http://www.drreddys.com/media/215437/press_release_sernivo_feb_2016.pdf
